Search

Abstract: The EURADOS (European Radiation Dosimetry Group) working group (WG2) on Harmonisation of Individual Monitoring in Europe has shown that intercomparisons are fundamental for harmonisation of individual monitoring. As a result of these considerations, EURADOS started to prepare a series of continuous intercomparisons for individual monitoring services (IMS) in Europe. EURADOS has now successfully executed two intercomparison exercises, one for whole body dosemeters (2008) and one for extremity dosemeters (2009). Both exercises were performed without external funding, all costs being covered by the participants’ fees. More than 120 (!) different – mainly passive – dosimetry systems were tested from all over Europe until now and the results were analysed and compared. Although scientific studies were not the primary objective of these exercises specific additional information about the tested systems supplied by the participants for statistical analysis allows a detailed analysis of these results with respect to different parameters like dosemeter type, detector material, filter thickness or others design parameters. The influence of such parameters on the response values of the dosemeters is analysed and discussed in this paper. Both energy response as well as directional response for beta and photon radiation are considered. The influence of different design parameters e.g. detector material, is analysed by comparing the frequency distribution of the response values for different dosemeter groups. Pronounced differences for different detector materials (LiF:Mg,Ti, LiF:Mg,Cu,P and Li2B4O7/CaSO4) were found. The paper gives a comprehensive overview on the performance of various European dosimetry services and the influence of the dosemeter design on the resulting response values. [Copyright &y& Elsevier]

Abstract: 90Y-labelled radiopharmaceuticals offer promising prospects for radionuclide therapies of tumours, e.g. radioimmunotherapies (RIT), (), peptide receptor radiotherapies (PRRT), (), and selective internal radiotherapies (SIRT), (). 90Y, an almost pure high-energy beta radiation emitter (Eβ,max = 2.28 MeV), is a favourable radionuclide for therapeutic purposes. However, when preparing and performing these therapies, high activities of 90Y (>1 GBq) are to be manipulated and technicians, physicians and nurses may receive high skin exposures to the hands. If radiation protection standards are low, the exposure of staff can exceed the annual skin dose limit of 500 mSv. Within a particular work package (WP4) of the ORAMED project, comprehensive measurements in nuclear medicine departments of several hospitals in 6 European countries were carried out. The study focussed on 90Y-labelled substances such as Zevalin® and DOTATOC to achieve a representative database on staff exposure. This paper summarises the most important results and conclusions for individual monitoring of skin exposure of staff. [Copyright &y& Elsevier]

Abstract: Twenty-five years ago, the SUPERLUMI setup at HASYLAB went into operation. In the meantime, the setup is used as a facility by many groups from Europe. In the present paper, history, continuous improvements, performance and scientific output of SUPERLUMI are described. [Copyright &y& Elsevier]